Skip to main content
Veterinary Medicines

NEMOVAC, lyofilizát pro přípravu orální suspenze, Lyofilizát pro orální suspenzi

Authorised
  • Turkey rhinotracheitis virus, strain PL21, Live

Product identification

Medicine name:
NEMOVAC, lyofilizát pro přípravu orální suspenze, Lyofilizát pro orální suspenzi
Active substance:
  • Turkey rhinotracheitis virus, strain PL21, Live
Target species:
  • Chicken
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain PL21, Live
    4.00
    log10 cell culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oral suspension
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD01
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/064/99-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 22/06/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 22/06/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 22/06/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."